Skip to main content
倍

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 357 across all filing types
Latest filing 2026-04-14 Annual Report
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2025年年度报告摘要
Annual Report Classification · 1% confidence The document is titled '年度报告摘要' (Annual Report Summary) for the year 2025, issued by Sichuan Qianli-beoka Medical Technology Inc. It contains key financial data, business summaries, shareholding structures, and management statements. While it is a summary, it serves as the primary disclosure of the annual financial results for the company, which aligns with the definition of an Annual Report (10-K) in the context of financial reporting standards. FY 2025
2026-04-14 Chinese
2025年年度业绩预告及业绩快报修正公告
Earnings Release Classification · 1% confidence The document is a formal announcement by a listed company revising its previously issued annual performance forecast and quick report (“2025年年度业绩预告及业绩快报修正公告”). It provides key financial metrics (revenue, profit, EPS adjustments) and explanations for the corrections, but is not the full annual report itself. This aligns with an earnings release (preliminary results/forecast announcements). FY 2025
2026-04-14 Chinese
2025年度独立董事述职报告（聂采现）
Governance Information Classification · 1% confidence The document is an Independent Director’s annual work report (“独立董事述职报告”), detailing governance activities, board attendance, committee participation, and oversight responsibilities under relevant laws and listing rules. It is not announcing board changes (MANG), nor is it an earnings or financial report. It fits within corporate governance disclosures on internal rules and director responsibilities. Therefore, it falls under Governance Information (CGR).
2026-04-14 Chinese
2025年度独立董事述职报告（王伦刚）
Governance Information Classification · 1% confidence The document is the “2025年度独立董事述职报告” by an independent director, presenting detailed governance activities, board and committee attendance, internal control oversight, and compliance with legal and listing rules. It is not an announcement of a board change, financial results, or dividend but a governance disclosure on board practices and director duties. This best aligns with Governance Information (CGR).
2026-04-14 Chinese
审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 1% confidence The document is a detailed report by the company’s Audit Committee on its supervisory activities over the external audit firm for the 2025 fiscal year. It contains descriptions of audit firm qualifications, oversight procedures, meeting dates, and committee evaluations. It is a standalone audit-related report and not the full annual report. Therefore, it fits the “Audit Report / Information” category (AR).
2026-04-14 Chinese
第四届董事会第六次会议决议公告
Board/Management Information Classification · 1% confidence The document is an announcement of the resolutions from the 6th meeting of the 4th Board of Directors of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details board meeting convening, attendance, and the approval of various corporate governance items (manager report, board report, audit report, financial budget, board member nomination, etc.). This falls under ‘Board/Management Information’ rather than an earnings release, audit report, or AGM materials. Therefore, it should be classified as MANG.
2026-04-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.